US Drug Recall Register
Class II · Moderate risk Terminated Initiated Sep 6, 2019 (7 years ago)

Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.

What was recalled

Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-453-01.

Recalling firm
Torrent Pharma Inc.
NDC code
13668-453-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1862-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Anagrelide recalls

See all